Tech Company Financing Transactions

Aeovian Pharmaceuticals Funding Round

CTI Life Sciences Fund, LUMA Capital Partners and Apollo Health Ventures participated in a $55 million venture round for Aeovian Pharmaceuticals. This VC investment round was recorded on 12/16/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
San Francisco, CA 94105
USA

Phone

Undisclosed

Website

www.aeovian.com

Email Address

Not Recorded

Overview

We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stelios Tzannis

        

Chief Financial Officer

Benjamin Zadik

        

VP - Regulatory Affairs

Curtis Scribner

        

Browse more venture capital transactions:

Prev: 12/16/2025: Cofactor Genomics venture capital transaction
Next: 12/16/2025: MyDello venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary